BIOCON LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 306.4 INR | +5.06% |
|
+17.10% | +22.73% |
| 04-18 | India's Biocon developing its own version of Wegovy, clinical trial likely next year | RE |
| 04-18 | Biocon Signs Licensing and Supply Pact with Biomm to Commercialize Generic Ozempic in Brazil | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BIOCON LIMITED | Bio Therapeutic Drugs | +5.06% | +17.10% | +22.73% | +31.53% | -1.26% | 4.39B |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- BIOCON Stock
- Charts Biocon Limited
- Comparison Chart
